The Japanese word "Hakko," meaning fermentation, reflects our core expertise, fueling the creation of premium, science-backed bioactive ingredients like Cognizin® Citicoline and Setria® Glutathione. Rooted in over 75 years of biotech innovation and Kirin’s century-long fermentation legacy, we deliver sustainable, high-impact solutions for the nutraceutical, pharmaceutical, and wellness industries, advancing Kirin’s mission to enhance quality of life and address societal health needs.
Our production site is located in Japan. We supply raw materials essential for the manufacturing of pharmaceuticals and health foods, which are indispensable for people's lives, to customers around the world. Our employees at the production site actively work to ensure product safety and maintain a stable supply.
Hofu Plant
The history of the Hofu Plant dates back to 1949, when it was established by Kyowa Hakko Kogyo. It was here that Kyowa succeeded in producing alcohol and the mass production of streptomycin for the first time in Japan. By constantly adopting the latest technologies, we developed the world's first fermentation method for producing L-glutamic acid. We succeeded in industrializing L-glutamic acid and began its mass production. We have since then been leading the world in biotechnology for more than half a century.
